Top Ten Imported Veterinary Medicines Quarterly Report Q1 2026

The UK Veterinary Medicines Directorate published its quarterly statistical report on certificates issued under the Special Import System for Q1 2026. Artuvetrin Therapy led with 3,256 certificates (27% of total), followed by Arthramid Vet with 1,346 certificates (11%). The top ten products collectively account for 58% of all certificates issued during the period. This is an informational report with no regulatory obligations or compliance requirements.

VMD Standards Performance Report, March 2026

VMD Standards Performance Report, March 2026

Donna Ockenden Appointed Chair of Independent Sussex Maternity Review

The UK Department of Health and Social Care has announced the appointment of Donna Ockenden as Chair of an independent review into Sussex maternity and neonatal services. Ockenden, known for leading the Shrewsbury and Telford NHS Trust review, was confirmed following direct engagement between the Health Secretary and bereaved families who campaigned for an independent review. The review is part of a government initiative to improve maternity safety across the NHS.

Clinical Trial Setup Time Falls to 122 Days

DHSC announces that average setup time for commercial interventional clinical trials in the UK has fallen to 122 days, down from 169 days for the same period last year. The £137 million investment in health research reforms has streamlined processes and reduced bureaucracy. This progress advances the Prime Minister's commitment to get UK clinical trials up and running within 150 days by March 2026.

Renewed Women's Health Strategy for England

The DHSC has published the Renewed Women's Health Strategy for England, a 10-year plan outlining how the government will improve women's health and healthcare. The strategy aligns with the 10 Year Health Plan for England and aims to ensure women have voice, choice and power in their health and healthcare. The strategy was published on 15 April 2026.

MHRA Annual Accountability Review Minutes 2015 to 2025

The Department of Health and Social Care has published transparency data listing MHRA annual accountability review minutes from 2014-15 through 2024-25. The page was updated on 15 April 2026 to add the 2024-25 review minutes from 29 October 2025. No new compliance obligations are created by this administrative listing.

Renewed Women's Health Strategy Published by DHSC and NHS England

DHSC and NHS England have published the renewed Women's Health Strategy, announcing plans to improve women's healthcare experiences across England. Key initiatives include a trial linking women's feedback to provider funding, a single referral point to reduce waiting lists for conditions like endometriosis, and new standards for pain relief during gynaecological procedures. The strategy aims to address systemic issues where women's symptoms have been dismissed or inadequately treated.

HIV and AIDS Reporting System: NHS Quarterly Data Collection Guidance

The UK Health Security Agency (UKHSA) updated its guidance on HIV surveillance systems, describing three reporting mechanisms: HARS (quarterly disaggregate data from NHS-funded HIV outpatient providers in England), HANDD (new diagnoses and deaths from laboratories and sexual health services), and CHARS (clinical data on children with HIV). Data from Scotland, Northern Ireland, and Wales is submitted annually and linked to create a UK-wide HIV database.

HIV Annual Data 2025: Testing, PrEP, New Diagnoses and Care Outcomes

UKHSA published annual HIV surveillance data for 2025 covering HIV testing, PrEP, PEP, new diagnoses, AIDS, deaths, and care outcomes across England, Wales, Northern Ireland, and Scotland. Data tables include demographic breakdowns, geographic region analysis, and key population statistics from 2015 to 2024. A slide set for presentational use is also available.

NOIDs Causative Agents: Weekly Reports for 2026

UKHSA publishes weekly lab reports on notifiable diseases and causative agents for 2026. The data covers weeks 1 through 15 (January through April 2026) with separate HTML reports for each week. The list of reportable organisms has been expanded to include additional notifiable organisms under updated requirements. Affected parties should monitor these weekly publications as the reporting requirements may have been updated to include new organisms that laboratories must notify UKHSA about.